Back
Reshape Lifesciences Quote, Financials, Valuation and Earnings
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
34
RSLS
Reshape Lifesciences
Last Price:
0.16
Seasonality Move:
-15.67%
7 Day Trial
ALL ACCESS PASS
$
7
How Banks Can Seize Your Accounts
Learn MoreReshape Lifesciences Price Quote
$0.16
-0.01 (-4.65%)
(Updated: September 16, 2024 at 3:00 PM ET)
Reshape Lifesciences Key Stats
Sell
34
Reshape Lifesciences (RSLS)
is a Sell
Day range:
$0.16 - $0.17
52-week range:
$0.14 - $0.79
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.39
P/B ratio:
1.62%
Volume:
239.3K
Avg. volume:
382.1K
1-year change:
-77.92%
Market cap:
$4.9M
Revenue:
$8.7M
EPS:
$-1.24
How Much Does Reshape Lifesciences Make?
-
How Much Are Reshape Lifesciences's Sales Annually?
RSLS Revenues are $8.7M -
How Much Profit Does Reshape Lifesciences's Make A Year?
RSLS net income is -$11.4M
Is Reshape Lifesciences Growing As A Company?
-
What Is Reshape Lifesciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.13% -
What Is Reshape Lifesciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Reshape Lifesciences Stock Price Performance
-
Did Reshape Lifesciences Stock Go Up Last Month?
Reshape Lifesciences share price went down by -3.51% last month -
Did RSLS's Share Price Rise Over The Last Year?
RSLS share price fell by -77.92% over the past 1 year
What Is Reshape Lifesciences 52-Week High & Low?
-
What Is Reshape Lifesciences’s 52-Week High Share Price?
Reshape Lifesciences has traded as high as $0.79 over the past 52 weeks -
What Is Reshape Lifesciences’s 52-Week Low Share Price?
Reshape Lifesciences has traded as low as $0.14 over the past 52 weeks
Reshape Lifesciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Reshape Lifesciences?
-
How Much Debt Does Reshape Lifesciences Have?
Total long term debt quarterly is $0 -
How Much Cash Does Reshape Lifesciences Have?
Cash and short term investments quarterly total is $1.1M -
What Is Reshape Lifesciences’s Book Value Per Share?
Book value per share is 0.10
Is Reshape Lifesciences Cash Flow Positive?
-
What Is RSLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$8.7M -
What Is Reshape Lifesciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Reshape Lifesciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Reshape Lifesciences Return On Invested Capital
-
Is Management Doing A Good Job?
RSLS return on invested capital is -187.5% -
What Is Reshape Lifesciences Return On Assets?
ROA measures how assets are converting to revenues and is -100.3% -
What Is RSLS Return On Equity?
ROE is a measure of profitability and is -187.5%
Reshape Lifesciences Earnings Date & Stock Price
-
What Is Reshape Lifesciences's Stock Price Today?
A single share of RSLS can be purchased today for 0.17 -
What Is Reshape Lifesciences’s Stock Symbol?
Reshape Lifesciences trades on the nasdaq under the ticker symbol: RSLS -
When Is Reshape Lifesciences’s Next Earnings Date?
The next quarterly earnings date for Reshape Lifesciences is scheduled on November 8, 2024 -
When Is RSLS's next ex-dividend date?
Reshape Lifesciences's next ex-dividend date is September 16, 2024 -
How To Buy Reshape Lifesciences Stock?
You can buy Reshape Lifesciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Reshape Lifesciences Competitors
-
Who Are Reshape Lifesciences's Competitors?
Below is a list of companies who compete with Reshape Lifesciences or are related in some way:
Reshape Lifesciences Dividend Yield
-
What Is RSLS Dividend Yield?
Reshape Lifesciences’s dividend yield currently is 0% -
What Is Reshape Lifesciences’s Payout Ratio?
Reshape Lifesciences’s payout ratio is 0% -
When Did Reshape Lifesciences Last Pay A Dividend?
The latest dividend pay date is September 16, 2024 -
What Is Reshape Lifesciences’s Dividend Per Share?
Reshape Lifesciences pays a dividend of $0.00 per share
Reshape Lifesciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 41% |
| Revenue: | -12.82% | -7.61% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 1.00 |
| Upside from Last Price: | 495.95% |